Clinical trial
A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively…
NCT00300664 · Royal Marsden NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00300664 |
|---|---|
| Title | A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | Human Growth hormone |
| Enrollment | 150 |
| Start date | Jul 1, 2002 |
| Completion | Apr 1, 2005 |
| First posted | Mar 9, 2006 |
| Last update posted | Oct 13, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: